NVAX EBITDA
Novavax Inc · EBITDA
NVAX EBITDA
Latest reported-$205.59Mperiod ending
NVAX EBITDA (-$5.20M → -$205.59M)
Annual EBITDA
High-resolution chart · PNG
NVAX ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 492,327,000 | |
| -108,044,000 | |
| -487,390,000 | |
| -604,713,000 | |
| -1,680,748,000 | |
| -398,229,000 | |
| -113,406,000 | |
| -162,977,000 | |
| -159,880,000 | |
| -258,496,000 | |
| -150,713,000 | |
| -78,366,000 | |
| -49,207,000 | |
| -26,809,000 | |
| -17,330,000 | |
| -35,708,000 | |
| -38,374,000 | |
| -33,746,000 | |
| -28,590,000 | |
| -18,288,000 | |
| -5,366,000 | |
| -21,023,000 | |
| -14,868,000 | |
| -20,420,000 | |
| -5,766,000 | |
| -12,148,000 | |
| -4,200,000 | |
| -4,900,000 | |
| -4,500,000 | |
| -5,200,000 |